Novel Surgical Procedure Helps Olivia Avoid Intestinal Transplant and Enjoy Her Life Again
In her early 20s, at an age when most young adults are busy exploring their expanding worlds, Olivia DeKold found hers becoming smaller and smaller.
Although she’d been living with a chronic condition called intestinal pseudoobstruction, or intestinal failure, since she was 2 years old, her symptoms from the motility disorder—including nausea, vomiting, stomach distention and pain—had been manageable. Right around the time she graduated from high school and was starting college, though, Olivia began noticing warning signs that something was wrong.
“That’s the way my disease works,” she said. “It’s hardly ever like one minute you’re OK and the next you’re in a lot of pain. It creeps up on you.”
Olivia began vomiting more than usual and noticing severe pain around her stoma, which is an opening in the abdomen created by doctors to remove waste from the body. By late 2022, Olivia had become so uncomfortable that she rarely left the house.
“I was so miserable,” she said. “Every time I ate, I threw up. The only thing I was doing was lying in bed. I told my doctor it might be time for a transplant.”
A Non-Transplant Surgical Option
Olivia had been a patient at Cincinnati Children’s since her diagnosis. Her doctor, Samuel Kocoshis, MD—medical director of the Intestinal Transplant Program—had always considered a complete intestinal transplant as only a last resort.
Patients like Olivia, along with others who have conditions that significantly affect their digestive system cannot eat or drink enough to survive so they rely on intravenous nutrition (total parenteral nutrition, or TPN), to get their required nutrients.
However, when patients are on TPN for a long period of time, they risk developing advanced liver disease or running out of available veins to place a central line, which supports TPN. At that point, doctors typically recommend an intestinal transplant as the last treatment option, but transplants come with their own set of risks, most related to rejection and infection due to the immunosuppression.